左炔诺孕酮宫内节育系统治疗子宫腺肌病患者的疗效和不良反应观察

doi:10.3785/j.issn.1008-9292.2019.04.02

浙江大学学报（医学版）

2019, Vol. 48

Issue (2): 130-135 DOI: 10.3785/j.issn.1008-9292.2019.04.02

子宫腺肌病非手术治疗

左炔诺孕酮宫内节育系统治疗子宫腺肌病患者的疗效和不良反应观察

张丽凤¹(

),杨慧²,张信美¹,陈正云^1,*(

)

1. 浙江大学医学院附属妇产科医院妇二科, 浙江杭州 310006
2. 湖南省妇幼保健院, 湖南长沙 410008

Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis

ZHANG Lifeng¹(

),YANG Hui²,ZHANG Xinmei¹,CHEN Zhengyun^1,*(

)

1. Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
2. Hunan Maternal and Child Health Hospital, Changsha 410008, China

全文: PDF(914 KB)

HTML( 20 )

摘要：

目的: 探讨左炔诺孕酮宫内节育系统（曼月乐）治疗子宫腺肌病的疗效和不良反应。方法: 回顾性分析2013年9至12月于浙江大学医学院附属妇产科医院因子宫腺肌病就诊并放置曼月乐的患者75例，共随访39个月，观察曼月乐的疗效和不良反应。结果: 月经量增多和月经量正常的患者放置曼月乐后月经量评分均降低（118±13和29±33，82±15和14±13，均P < 0.01），月经量增多者比月经量正常者的月经量评分降低更明显（90±35和69±19，P < 0.01）。放置曼月乐后患者痛经评分降低[7（6，7）和1（0，2），P < 0.01]。患者发生曼月乐脱落18例（24.0%），放置曼月乐无效9例（12.0%），发生月经模式改变28例（37.3%）。多因素Cox回归分析未发现治疗后痛经评分、治疗前后月经量评分和月经稳定时间与曼月乐环脱落相关（均P>0.05）。结论: 曼月乐在子宫腺肌病的长期保守治疗中总体安全有效，约1/3的患者可能因曼月乐脱落或治疗无效接受进一步治疗。

关键词： 子宫腺肌病/药物疗法; 宫内避孕器, 含药/副作用; 左炔诺孕酮/治疗应用; 治疗结果

Abstract:

Objective: To evaluate the efficacy and adverse effects of levonorgestrel-releasing intrauterine system (Mirena) in the treatment of adenomyosis. Methods: The clinical data of 75 patients with adenomyosis who had Mirena insertion in Women's Hospital, Zhejiang University School of Medicine from September 2013 to December 2013 were retrospectively analyzed. The patients were followed up to 39 months. The efficacy and adverse effects were assessed. Results: Pictorial Blood Loss Assessment Chart (PBAC) scores were decreased significantly after Mirena insertion both in patients with menorrhea (118±13 vs. 29±33, P < 0.01) and normal menstruation (82±15 vs. 14±13, P < 0.01); the patients with menorrhea showed a more significant decrease in PBAC score than those with normal menstruation (90±35 vs. 69±19, P < 0.01). The visual analogue scale (VAS) score decreased significantly after Mirena insertion compared with pre-treatment[7(6, 7) vs. 1(0, 2), P < 0.01]. The expulsion of Mirena occurred in 18 cases (24.0%); 9 cases (12.0%) had no effect and 28 cases (37.3%) had changes of menstruation patterns. Multivariate Cox regression analysis showed that the expulsion of Mirena was not associated with post-treatment VAS score, PBAC score before and after treatment or menstrual stabilization time (all P>0.05). Conclusion: Mirena is effective and safe in the long term management of adenomyosis, but about one third patients may require further treatment because of the expulsion or ineffectiveness of Mirena.

Key words: Adenomyosis/drug therapy Intrauterine devices, medicated/adverse effects Levonorgestrel/therapeutic use Treatment outcome

收稿日期: 2019-01-26 出版日期: 2019-07-24

CLC:

R711.74

基金资助: 国家重点研发计划(2017YFC1001202)

通讯作者: 陈正云 E-mail: lfzhang1993@163.com;5504004@zju.edu.cn

作者简介: 张丽凤(1993-), 女, 硕士研究生, 主要从事子宫内膜异位症和子宫腺肌病临床研究; E-mail:lfzhang1993@163.com; https://orcid.org/000-0002-1414-4043

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张丽凤
	杨慧
	张信美
	陈正云

引用本文:

张丽凤,杨慧,张信美,陈正云. 左炔诺孕酮宫内节育系统治疗子宫腺肌病患者的疗效和不良反应观察[J]. 浙江大学学报（医学版）, 2019, 48(2): 130-135.

ZHANG Lifeng,YANG Hui,ZHANG Xinmei,CHEN Zhengyun. Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis. J Zhejiang Univ (Med Sci), 2019, 48(2): 130-135.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.04.02 或 http://www.zjujournals.com/med/CN/Y2019/V48/I2/130

表 1 曼月乐脱落危险因素的单因素分析结果

表 2 曼月乐脱落危险因素的多因素Cox回归分析结果

1	EXACOUSTOS C , ZUPI E . A new era in diagnosing adenomyosis is coming[J]. Fertil Steril, 2018, 110 (5): 858 doi: 10.1016/j.fertnstert.2018.07.005
2	PARK D S , KIM M L , SONG T et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis[J]. Taiwan J Obstet Gynecol, 2015, 54 (4): 412- 415 doi: 10.1016/j.tjog.2014.05.009
3	OZDEGIRMENCI O , KAYIKCIOGLU F , AKGUL M A et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis[J]. Fertil Steril, 2011, 95 (2): 497- 502 doi: 10.1016/j.fertnstert.2010.10.009
4	SPENCER J C, LOUIE M, MOULDER J K, et al. Cost-effectiveness of treatments for heavy menstrual bleeding[J/OL]. Am J Obstet Gynecol, 2017, 217(5): 574.e1-574.e9.
5	YOUM J , LEE H J , KIM S K et al. Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system[J]. Int J Gynaecol Obstet, 2014, 126 (2): 165- 169 doi: 10.1016/j.ijgo.2014.02.017
6	KIM M K , CHON S J , LEE J H et al. Postoperative levonorgestrel-releasing intrauterine system insertion after gonadotropin-releasing hormone agonist treatment for preventing endometriotic cyst recurrence:a prospective observational study[J]. Reprod Sci, 2018, 25 (1): 39- 43 doi: 10.1177/1933719117718274
7	冯力民, 夏恩兰, 黄晓武 et al. 应用月经失血图评估月经血量[J]. 中华妇产科杂志, 2001, 36 (1): 51 FENG Limin , XIA Enlan , HUANG Xiaowu et al. Application of pitorial blood loss assessment[J]. Chinese Journal of Obstetrics and Gynecology, 2001, 36 (1): 51 doi: 10.3760/j.issn:0529-567X.2001.01.019
8	中华医学会妇产科学分会子宫内膜异位症协作组 . 子宫内膜异位症的诊治指南[J]. 中华妇产科杂志, 2015, 50 (3): 161- 169 Collaborative Group of Adenomyosis, Society of Obstetrics and Gynecology, Chinese Medical Association . Guideline for diagnosis and treatment of adenomyosis[J]. Journal of Obstetrics and Gynecology, 2015, 50 (3): 161- 169 doi: 10.3760/cma.j.issn.0529-567x.2015.03.001
9	CHOI Y S , CHO S , LIM K J et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis[J]. Growth Factors, 2010, 28 (6): 452- 460 doi: 10.3109/08977194.2010.511619
10	李雷, 冷金花, 史精华 et al. LNG-IUS治疗子宫腺肌病相关经量过多的前瞻性研究[J]. 中华妇产科杂志, 2016, 51 (6): 424- 430 LI Lei , LENG Jinhua , SHI Jinghua et al. A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia[J]. Journal of Obstetrics and Gynecology, 2016, 51 (6): 424- 430 doi: 10.3760/cma.j.issn.0529-567x.2016.06.005
11	SHAABAN O M , ALI M K , SABRA A M et al. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri:a randomized clinical trial[J]. Contraception, 2015, 92 (4): 301- 307 doi: 10.1016/j.contraception.2015.05.015
12	MAWET M , NOLLEVAUX F , NIZET D et al. Impact of a new levonorgestrel intrauterine system, Levosert(?), on heavy menstrual bleeding:results of a one-year randomised controlled trial[J]. Eur J Contracept Reprod Health Care, 2014, 19 (3): 169- 179 doi: 10.3109/13625187.2014.894184
13	CHO S, NAM A, KIM H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis[J/OL]. Am J Obstet Gynecol, 2008, 198(4): 373.e1-7.
14	SHENG J , ZHANG W Y , ZHANG J P et al. The LNG-IUS study on adenomyosis:a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis[J]. Contraception, 2009, 79 (3): 189- 193 doi: 10.1016/j.contraception.2008.11.004
15	李雷, 冷金花, 张俊吉 et al. LNG-IUS治疗症状性子宫腺肌病过程中月经模式的改变与不良反应[J]. 中华妇产科杂志, 2016, 51 (9): 657- 662 LI Lei , LENG Jinhua , ZHANG Junji et al. Changes of menstruation patterns and adverse effects during the treatment of LNG-IUS for symptomatic adenomyosis[J]. Journal of Obstetrics and Gynecology, 2016, 51 (9): 657- 662 doi: 10.3760/cma.j.issn.0529-567x.2016.09.004
16	ONTARIO H Q . Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding:a health technology assessment[J]. Ont Health Technol Assess Ser, 2016, 16 (18): 1- 119
17	ZHANG P , SONG K , LI L et al. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis[J]. Med Princ Pract, 2013, 22 (5): 480- 483 doi: 10.1159/000351431
18	李雷, 冷金花, 贾双征 et al. 左炔诺孕酮宫内缓释系统治疗子宫腺肌病计划外取出和脱落情况及其相关因素分析[J]. 中国实用妇科与产科杂志, 2016, 32 (11): 1088- 1092 LI Lei , LENG Jinhua , JIA Shuangzheng et al. Analysis of unplanned taking-out and expulsion of LNG-IUS and related factors during the treatment of symptomatic adenomyosis[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2016, 32 (11): 1088- 1092
19	LEE K H , KIM J K , LEE M A et al. Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis[J]. Arch Gynecol Obstet, 2016, 294 (3): 561- 566 doi: 10.1007/s00404-016-4105-y
20	RADZINSKY V E , KHAMOSHINA M B , NOSENKO E N et al. Treatment strategies for pelvic pain associated with adenomyosis[J]. Gynecol Endocrinol, 2016, 32 (sup2): 19- 11 doi: 10.1080/09513590.2016.1232673
21	张信美, 许泓, 黄秀峰 et al. 左炔诺孕酮宫内缓释系统治疗子宫腺肌病的长期疗效观察[J]. 中华妇产科杂志, 2009, 44 (9): 694- 696 ZHANG Xinmei , XU Hong , HUANG Xiufeng et al. Long term efficacy of levonorgestrel releasing intrauterine system in treatment of adenomyosis[J]. Journal of Obstetrics and Gynecology, 2009, 44 (9): 694- 696 doi: 10.3760/cma.j.issn.0529-567x.2009.09.016

[1]	楼俊瑶,黄秀峰,张丽凤,徐萍,张信美,陈正云. 第二代子宫内膜消融术可提高左炔诺孕酮宫内节育系统对子宫腺肌病患者的疗效[J]. 浙江大学学报（医学版）, 2019, 48(2): 136-141.
[2]	张信美,徐萍. 子宫腺肌病分层治疗及管理[J]. 浙江大学学报（医学版）, 2019, 48(2): 123-129.
[3]	沈宏,季峰. 无X射线监视内镜下消化道支架置入治疗消化道狭窄的疗效和安全性[J]. 浙江大学学报（医学版）, 2018, 47(6): 643-650.
[4]	尹孝亮,郎德海,王迪. 经皮机械血栓清除治疗急性髂股静脉血栓形成患者疗效观察[J]. 浙江大学学报（医学版）, 2018, 47(6): 588-594.
[5]	林作栋,郎德海. 经皮机械血栓清除联合球囊血管成形治疗髂股静脉血栓形成患者疗效分析[J]. 浙江大学学报（医学版）, 2018, 47(6): 595-600.
[6]	王晓辉,何杨燕,吴子衡,张鸿坤. 一体化微创手术治疗髂静脉压迫综合征伴下肢静脉曲张患者疗效观察[J]. 浙江大学学报（医学版）, 2018, 47(6): 577-582.
[7]	余钻标,林作栋,郎德海. 经皮机械血栓清除联合支架植入治疗急性髂股静脉血栓形成患者中远期疗效评估[J]. 浙江大学学报（医学版）, 2018, 47(6): 623-627.
[8]	邓璇,何寒青,周洋,潘金仁,严睿,唐学雯,符剑. 水痘疫苗不同免疫策略的卫生经济学评价[J]. 浙江大学学报（医学版）, 2018, 47(4): 374-380.
[9]	徐玮泽,叶菁菁,李建华,张泽伟,俞建根,石卓,俞劲,舒强. 单纯食管超声心动图引导经皮房间隔缺损封堵术治疗房间隔缺损患儿的疗效[J]. 浙江大学学报（医学版）, 2018, 47(3): 244-249.
[10]	张玉喜,莫绪明,孙剑,彭卫,戚继荣,武开宏,束亚琴. 胸腔镜手术治疗Ⅲ型食管闭锁合并气管食管瘘新生儿的疗效[J]. 浙江大学学报（医学版）, 2018, 47(3): 266-271.
[11]	张士松,武玉睿,刘红真,翟允鹏,刘威. 复杂型先天性肠闭锁患儿治疗体会[J]. 浙江大学学报（医学版）, 2018, 47(3): 255-260.
[12]	吕成杰,胡东来,黄寿奖,秦琪,赵晓霞,胡书奇,张雅楠,方旋,郭晓东,钭金法. 经脐单部位腹腔镜手术治疗新生儿先天性十二指肠梗阻的疗效和安全性观察[J]. 浙江大学学报（医学版）, 2018, 47(3): 261-265.
[13]	祝子逸,郦志军,何正富,王云震. 内镜引导下吻合口瘘冲洗治疗食管胃吻合口瘘合并瘘旁脓肿临床疗效观察[J]. 浙江大学学报（医学版）, 2017, 46(6): 637-642.
[14]	陆薇,林梦娜,赵士芳,王慧明,何福明. 改良侧壁开窗式上颌窦底提升术治疗上颌后牙区缺牙伴重度骨萎缩患者临床观察[J]. 浙江大学学报（医学版）, 2017, 46(6): 630-636.
[15]	张思影等. CT和磁共振参数反应图在肿瘤精准疗效评估中的研究进展[J]. 浙江大学学报（医学版）, 2017, 46(5): 468-472.

Viewed

Full text

Abstract

Cited

Shared

Discussed